|
LB Pharmaceuticals Inc |
Common Stock, $0.0001 par value per share |
14.9% |
|
|
3.35M |
|
Deep Track Capital, LP |
Sep 12, 2025 |
| DVAX |
Dynavax Technologies Corporation |
Common Stock, $0.001 par value |
13.41% |
$162M |
-$21.2M |
15.7M |
-11.6% |
Deep Track Biotechnology Master Fund, Ltd. |
Aug 22, 2025 |
| VSTM |
Verastem, Inc. |
Common stock, $0.0001 par value per share |
9.99% |
$60.3M |
|
7.72M |
|
Deep Track Capital, LP |
Nov 14, 2025 |
| CMPS |
COMPASS Pathways plc |
American Depositary Shares, each representing one ordinary share, par value of (pound)0.008 per share |
9.99% |
$26.4M |
|
9.27M |
|
Deep Track Capital, LP |
Jan 10, 2025 |
| XFOR |
X4 Pharmaceuticals, Inc. |
Common Stock, par value $0.001 per share |
9.99% |
$9.28M |
|
2.37M |
|
Deep Track Capital, LP |
Aug 12, 2025 |
| PALI |
PALISADE BIO, INC. |
Common Stock, par value $0.01 per share |
9.99% |
$5.81M |
|
10M |
|
Deep Track Capital, LP |
Oct 1, 2025 |
| RAPT |
RAPT Therapeutics, Inc. |
Common Stock $0.0001 par value per share |
9.87% |
$12M |
|
14.1M |
|
Deep Track Capital, LP |
Dec 23, 2024 |
| MAZE |
Maze Therapeutics Inc. |
Common Stock, $0.001 par value per share |
9.02% |
$54.8M |
$12.8M |
3.95M |
+30.6% |
Deep Track Capital, LP |
Jun 30, 2025 |
| TERN |
Terns Pharmaceuticals, Inc. |
Common Stock, $0.0001 par value per share |
8.58% |
$53M |
$13.6M |
7.5M |
+34.4% |
Deep Track Capital, LP |
Jun 30, 2025 |
| CNTX |
Context Therapeutics Inc. |
Common Stock, $0.001 par value per share |
8.27% |
$4.53M |
|
7.42M |
|
Deep Track Capital, LP |
Mar 31, 2025 |
|
IMAGENEBIO, INC. |
Common Stock, $0.001 par value |
7.86% |
|
|
879K |
|
Deep Track Capital, LP |
Jul 28, 2025 |
| GPCR |
Structure Therapeutics Inc. |
Ordinary Shares, $0.0001 par value |
7.32% |
$354M |
-$77.1M |
12.6M |
-17.9% |
Deep Track Capital, LP |
Sep 30, 2025 |
| NRIX |
Nurix Therapeutics, Inc. |
Common Stock, par value $0.001 per share |
7.21% |
$65.3M |
$16.3M |
5.5M |
+33.3% |
Deep Track Capital, LP |
Mar 31, 2025 |
| TARS |
Tarsus Pharmaceuticals, Inc. |
Common Stock, $0.0001 par value per share |
7.11% |
$178M |
$38.5M |
3M |
+27.5% |
Deep Track Capital, LP |
Sep 30, 2025 |
| JBIO |
Jade Biosciences, Inc. |
Common Stock, $0.0001 par value per share |
6.99% |
$19.7M |
-$4.36M |
2.28M |
-18.1% |
Deep Track Capital, LP |
Sep 30, 2025 |
| MNMD |
Mind Medicine (MindMed) Inc. |
Common Shares |
6.87% |
$64.8M |
-$11.8M |
5.5M |
-15.4% |
Deep Track Capital, LP |
Sep 30, 2025 |
| GERN |
Geron Corp |
Common Stock, $0.001 par value |
6.75% |
$62.8M |
$11.7M |
43M |
+22.9% |
Deep Track Capital, LP |
Jun 30, 2025 |
| ENGN |
enGene Holdings Inc. |
Common Shares |
6.69% |
$30M |
$14.5M |
4.32M |
+92.8% |
Deep Track Capital, LP |
Nov 11, 2025 |
| MBX |
MBX Biosciences, Inc. |
Common Stock, $0.0001 par value per share |
6.55% |
$30.4M |
|
2.19M |
|
Deep Track Capital, LP |
Jun 30, 2025 |
| MLTX |
MoonLake Immunotherapeutics |
Class A ordinary share, par value $0.0001 per share |
6.46% |
$33.1M |
|
4.61M |
|
Deep Track Capital, LP |
Nov 5, 2025 |
| ETNB |
89bio, Inc. |
Common stock, par value $0.001 per share |
6.31% |
$138M |
-$65.6M |
9.36M |
-32.3% |
Deep Track Capital, LP |
Sep 30, 2025 |
| OCUL |
Ocular Therapeutix, Inc |
Common Stock, $0.0001 par value per share |
6.18% |
$153M |
-$27.6M |
13.1M |
-15.3% |
Deep Track Capital, LP |
Sep 30, 2025 |
| CYBN |
CYBIN INC. |
Common Shares, no par value |
6.09% |
$18.1M |
$12.2M |
3.07M |
+207% |
Deep Track Capital, LP |
Oct 28, 2025 |
| IMVT |
Immunovant Inc. |
Common Stock, $0.0001 par value per share |
5.59% |
$139M |
|
9.5M |
|
Deep Track Capital, LP |
Mar 19, 2025 |
| APLS |
Apellis Pharmaceuticals, Inc. |
Common Stock, $0.0001 par value per share |
5.57% |
$126M |
|
7M |
|
Deep Track Capital, LP |
May 9, 2025 |
| AKRO |
Akero Therapeutics, Inc. |
Common Stock, par value $0.0001 per share |
5.5% |
$209M |
|
4.4M |
|
Deep Track Capital, LP |
Sep 30, 2025 |
| ENTA |
ENANTA PHARMACEUTICALS INC |
Common Stock, par value $0.01 per share |
5.33% |
$17.8M |
|
1.48M |
|
Deep Track Capital, LP |
Oct 2, 2025 |
| ORKA |
Oruka Therapeutics, Inc. |
Common Stock, par value $0.001 per share |
5.07% |
$17.9M |
|
1.9M |
|
Deep Track Capital, LP |
May 6, 2025 |
| OLMA |
Olema Pharmaceuticals, Inc. |
Common Stock, par value $0.0001 per share |
5.04% |
$10.9M |
|
3.44M |
|
Deep Track Capital, LP |
Mar 31, 2025 |
| ABVX |
Abivax SA |
Ordinary Shares (represented by American Depository Shares) |
4.78% |
$284M |
|
3.48M |
|
Deep Track Capital, LP |
Jun 30, 2025 |
| SWTX |
Springworks Therapeutics, Inc. |
Common Stock, par value $0.0001 per share |
4.65% |
$124M |
|
3.46M |
|
Deep Track Capital, LP |
Dec 31, 2024 |
| GH |
Guardant Health, Inc. |
Common Stock, $0.00001 Par Value |
4.41% |
$232M |
|
5.44M |
|
Deep Track Capital, LP |
Mar 31, 2025 |
| OKUR |
Onkure Therapeutics, Inc. |
Common Stock, par value $0.0001 per share |
4.14% |
$1.55M |
|
524K |
|
Deep Track Capital, LP |
Dec 31, 2024 |
| KRRO |
Korro Bio, Inc. |
Common stock, par value $0.001 per share |
2.96% |
$6.58M |
|
278K |
|
Deep Track Capital, LP |
Jun 30, 2025 |
| PTGX |
Protagonist Therapeutics, Inc |
Common Stock, par value $0.00001 |
2.76% |
$114M |
-$102M |
1.72M |
-47.2% |
Deep Track Capital, LP |
Sep 30, 2025 |
| BCYC |
Bicycle Therapeutics plc |
American Depositary Shares, each representing one ordinary share, nominal value (pound)0.01 per share |
2.42% |
$9.24M |
-$12.4M |
1.2M |
-57.3% |
Deep Track Capital, LP |
Jun 30, 2025 |
| INO |
INOVIO PHARMACEUTICALS, INC. |
Common Stock, $0.001 par value |
2.41% |
$3.08M |
|
1.31M |
|
Deep Track Capital, LP |
Sep 30, 2025 |
| FDMT |
4D Molecular Therapeutics Inc. |
Common Stock, par value $0.0001 per share |
1.32% |
$1.62M |
|
610K |
|
Deep Track Capital, LP |
Dec 31, 2024 |
| NKTR |
Nektar Therapeutics |
Common Stock, par value $0.0001 |
1.07% |
$968K |
|
1.98M |
|
Deep Track Capital, LP |
Dec 31, 2024 |
| AUTL |
Autolus Therapeutics plc |
American Depositary Shares, each representing one ordinary share, nominal value $0.000042 per share |
0.97% |
$4.19M |
|
2.57M |
|
Deep Track Capital, LP |
Sep 30, 2025 |
| ZURA |
Zura Bio Ltd |
Class A Ordinary Shares, $0.0001 par value |
0.4% |
$1.12M |
-$18.9M |
259K |
-94.4% |
Deep Track Capital, LP |
Sep 30, 2025 |
| ALLK |
Allakos Inc. |
Common Stock, par value $0.001 |
0% |
$0 |
-$2.39M |
0 |
-100% |
Deep Track Capital, LP |
Jun 30, 2025 |
| PLRX |
Pliant Therapeutics, Inc. |
Common Stock, par value $0.0001 per share |
0% |
$0 |
-$5.84M |
0 |
-100% |
Deep Track Capital, LP |
Sep 30, 2025 |
| RGLS |
Regulus Therapeutics Inc. |
Common Stock, par value $0.001 per share |
0% |
$0 |
|
0 |
|
Deep Track Capital, LP |
Jun 30, 2025 |
| TECX |
Tectonic Therapeutic, Inc. |
Common Stock $0.0001 par value per share |
0% |
$0 |
-$22M |
0 |
-100% |
Deep Track Capital, LP |
Sep 30, 2025 |
| DNTH |
Dianthus Therapeutics Inc. |
Common Stock, $0.001 Par Value |
0% |
$0 |
-$92.8M |
0 |
-100% |
Deep Track Capital, LP |
Sep 30, 2025 |
| IVVD |
Invivyd, Inc. |
Common stock, par value $0.0001 per share |
0% |
$0 |
-$10.7M |
0 |
-100% |
Deep Track Capital, LP |
Sep 30, 2025 |
| SYRS |
Syros Pharmaceuticals, Inc. |
Common Stock, $0.001 par value |
0% |
$0 |
|
0 |
|
Deep Track Capital, LP |
Dec 31, 2024 |
| EDIT |
Editas Medicine, Inc. |
Common Stock, $0.0001 par value per share |
0% |
$0 |
|
0 |
|
Deep Track Capital, LP |
Dec 31, 2024 |
| PYXS |
Pyxis Oncology, Inc. |
Common Stock, par value $0.001 per share |
0% |
$0 |
|
0 |
|
Deep Track Capital, LP |
Dec 31, 2024 |
| IKNA |
Ikena Oncology, Inc. |
Common Stock, $0.001 par value |
0% |
$0 |
-$2.67M |
0 |
-100% |
Deep Track Capital, LP |
Jul 28, 2025 |
| AVTX |
Avalo Therapeutics, Inc. |
Common Stock, $0.001 par value |
0% |
$0 |
|
0 |
|
Deep Track Capital, LP |
Sep 30, 2025 |